D-Glyceric acidemia: Difference between revisions

From WikiMD's Wellness Encyclopedia

CSV import
 
CSV import
Tags: mobile edit mobile web edit
Line 1: Line 1:
'''D-Glyceric acidemia''' is a rare inherited metabolic disorder characterized by the body's inability to properly process the amino acid glycine. This condition is caused by a deficiency of the enzyme D-glycerate kinase, which is involved in the breakdown of glycine. The disorder can lead to a variety of symptoms, including developmental delay, seizures, and failure to thrive.
== D-Glyceric Acidemia ==


== Symptoms ==
[[File:Autosomal recessive - en.svg|thumb|right|Diagram of autosomal recessive inheritance]]
The symptoms of D-Glyceric acidemia can vary greatly from person to person. Some individuals may experience only mild symptoms, while others may have severe neurological complications. Common symptoms include:


'''D-Glyceric Acidemia''' is a rare [[metabolic disorder]] characterized by the accumulation of [[D-glyceric acid]] in the body. This condition is caused by a deficiency in the enzyme [[glycerate kinase]], which is responsible for the metabolism of D-glyceric acid. As a result, individuals with this disorder experience a range of symptoms that can vary in severity.
=== Pathophysiology ===
D-Glyceric Acidemia is an [[inborn error of metabolism]] that affects the [[metabolic pathway]] responsible for the breakdown of [[serine]] and [[glycine]]. The deficiency in glycerate kinase leads to the accumulation of D-glyceric acid, which can be detected in the [[urine]] and [[blood]]. This accumulation can cause metabolic acidosis and other related symptoms.
=== Genetics ===
D-Glyceric Acidemia is inherited in an [[autosomal recessive]] pattern, meaning that an individual must inherit two copies of the defective gene, one from each parent, to be affected by the disorder. The gene responsible for this condition is located on chromosome 17.
=== Clinical Features ===
The clinical presentation of D-Glyceric Acidemia can vary widely among affected individuals. Common symptoms include:
* [[Developmental delay]]
* [[Developmental delay]]
* [[Hypotonia]]
* [[Seizures]]
* [[Seizures]]
* [[Metabolic acidosis]]
* [[Failure to thrive]]
* [[Failure to thrive]]
* [[Metabolic acidosis]]
* [[Hyperglycinemia]]


== Causes ==
=== Diagnosis ===
D-Glyceric acidemia is caused by mutations in the GLYCTK gene, which provides instructions for making the enzyme D-glycerate kinase. This enzyme is involved in the breakdown of the amino acid glycine. When the enzyme is deficient, glycine and D-glyceric acid can build up in the body, leading to the symptoms of the disorder.
Diagnosis of D-Glyceric Acidemia is typically made through a combination of clinical evaluation, biochemical testing, and genetic testing. Elevated levels of D-glyceric acid in the urine and blood are indicative of the disorder. Genetic testing can confirm the presence of mutations in the gene responsible for glycerate kinase.


== Diagnosis ==
=== Treatment ===
The diagnosis of D-Glyceric acidemia is typically made through a combination of clinical examination, laboratory testing, and genetic testing. Laboratory tests may include blood and urine tests to check for elevated levels of glycine and D-glyceric acid. Genetic testing can confirm the diagnosis by identifying mutations in the GLYCTK gene.
There is currently no cure for D-Glyceric Acidemia, and treatment is primarily supportive. Management strategies may include:
* Dietary modifications to reduce the intake of serine and glycine
* [[Bicarbonate]] therapy to manage metabolic acidosis
* [[Anticonvulsant]] medications to control seizures


== Treatment ==
=== Prognosis ===
There is currently no cure for D-Glyceric acidemia, and treatment is focused on managing the symptoms of the disorder. This may include medications to control seizures, dietary modifications to limit the intake of glycine, and other supportive therapies.
The prognosis for individuals with D-Glyceric Acidemia varies depending on the severity of the condition and the effectiveness of management strategies. Early diagnosis and intervention can improve outcomes and quality of life for affected individuals.


== See also ==
== Related Pages ==
* [[Metabolic disorder]]
* [[Metabolic disorder]]
* [[Glycine]]
* [[Inborn error of metabolism]]
* [[GLYCTK gene]]
* [[Autosomal recessive]]
* [[Metabolic acidosis]]


== References ==
{{Metabolic disorders}}
<references />


[[Category:Genetic disorders]]
[[Category:Metabolic disorders]]
[[Category:Metabolic disorders]]
[[Category:Genetic disorders]]
[[Category:Rare diseases]]
{{stub}}

Revision as of 16:28, 16 February 2025

D-Glyceric Acidemia

Diagram of autosomal recessive inheritance

D-Glyceric Acidemia is a rare metabolic disorder characterized by the accumulation of D-glyceric acid in the body. This condition is caused by a deficiency in the enzyme glycerate kinase, which is responsible for the metabolism of D-glyceric acid. As a result, individuals with this disorder experience a range of symptoms that can vary in severity.

Pathophysiology

D-Glyceric Acidemia is an inborn error of metabolism that affects the metabolic pathway responsible for the breakdown of serine and glycine. The deficiency in glycerate kinase leads to the accumulation of D-glyceric acid, which can be detected in the urine and blood. This accumulation can cause metabolic acidosis and other related symptoms.

Genetics

D-Glyceric Acidemia is inherited in an autosomal recessive pattern, meaning that an individual must inherit two copies of the defective gene, one from each parent, to be affected by the disorder. The gene responsible for this condition is located on chromosome 17.

Clinical Features

The clinical presentation of D-Glyceric Acidemia can vary widely among affected individuals. Common symptoms include:

Diagnosis

Diagnosis of D-Glyceric Acidemia is typically made through a combination of clinical evaluation, biochemical testing, and genetic testing. Elevated levels of D-glyceric acid in the urine and blood are indicative of the disorder. Genetic testing can confirm the presence of mutations in the gene responsible for glycerate kinase.

Treatment

There is currently no cure for D-Glyceric Acidemia, and treatment is primarily supportive. Management strategies may include:

  • Dietary modifications to reduce the intake of serine and glycine
  • Bicarbonate therapy to manage metabolic acidosis
  • Anticonvulsant medications to control seizures

Prognosis

The prognosis for individuals with D-Glyceric Acidemia varies depending on the severity of the condition and the effectiveness of management strategies. Early diagnosis and intervention can improve outcomes and quality of life for affected individuals.

Related Pages